查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529715

誘導性多功能幹細胞生產市場規模、佔有率、趨勢分析報告：按製程、按工作流程、按產品、按應用、按最終用途、按地區、細分市場預測，2024-2030 年

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

誘導性多功能幹細胞生產市場的成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球誘導性多功能幹細胞生產市場規模將達到27.6億美元，2024年至2030年複合年成長率為9.44%。

與胚胎幹細胞（ESC）相比，誘導性多功能幹細胞（iPSC）的需求不斷成長，顯著推動了市場的發展。幹細胞不存在倫理問題、個人化治療的可能性以及細胞研究的靈活性等優勢為市場成長創造了有利的前景。此外，慢性病的流行也推動了誘導性多功能幹細胞生產市場的成長。這是因為心臟病、中風、糖尿病和許多其他疾病都可以使用 iPS 細胞介導的療法來治療。例如，根據國際糖尿病聯盟 (IDF) 的數據，到 2021 年，將有 5.37 億人患有糖尿病。

COVID-19 大流行期間研究活動的增加對市場產生了積極影響。由於 SARS CoV-2 感染已導致患者患有多種疾病，此次疫情大流行促進了許多領域的研究。例如，2021年4月，美國研究人員表示，高達25%的COVID-19患者患有心臟功能障礙。透過他們的研究論文，他們證明這種疾病是由 iPS 細胞衍生的心臟細胞暴露於 SARS CoV-2 引起的，並且在患者的人體屍檢標本中也證實了類似的變化。這些見解使得能夠使用誘導性多功能幹細胞(iPSC) 作為開發藥物和治療方法的平台，以控制 COVID-19 的長期影響。

誘導性多功能幹細胞是源自成體細胞的細胞，並進一步重新編程以獲得類似 ESC 的多功能。事實證明，這些 iPS 細胞對於使用 ESC 進行研究來說是一個在倫理上合理的選擇。倫理爭論最激烈，因為胚胎幹細胞的產生涉及破壞胚囊階段的胚胎。然而，誘導性多功能幹細胞僅透過對體細胞進行基因重編程，就解決了研究中破壞人類胚胎的倫理問題。這推動了市場成長，並帶來了藥物發現、疾病建模和毒性測試等眾多應用。例如，2021年8月，Fate Therapeutics宣布臨床試驗中首例FT819患者接受治療。 FT819是一種源自iPS細胞的人工CAR-T細胞療法。由於其獨特的特性，如可再生潛力、自我更新潛力和免疫調節特性，研究界越來越關注探索誘導性多功能幹細胞在再生醫學中的應用，從而推動了市場的擴張。

誘導性多功能幹細胞生產市場報告亮點

  • 從製程來看，手動 iPSC 生產流程佔據市場主導地位，並在 2023 年佔據最大的收益佔有率。
  • 從工作流程來看，細胞培養細分市場佔據主導地位，2023 年收益佔有率最大，為 37.34%。細胞培養工作流程包括來自 iPSC 收穫產品、擴增產品和分化產品的收益，有助於提高該細分市場的市場相關性。
  • 按產品分類，耗材和套件細分市場佔據主導地位，2023 年收益佔有率最大，為 40.32%。 iPSC 領域的持續研發活動正在推動對各種耗材和套件的需求。
  • 從應用來看，藥物開發和發現領域佔據市場主導地位，2023 年銷售額佔有率最大，為 43.33%。
  • 以最終用途分類，生物技術和製藥公司細分市場佔據主導地位，2023 年收益佔有率最高，達 59.35%。各種套件、耗材和儀器以及 iPSC 產品的可用性和採用正在推動該領域的產生收入。
  • 北美地區主導市場，2023 年收益佔有率最大，為 40.98%。該地區慢性病患病率的上升、發達的醫療基礎設施、私人和政府舉措的資金以及戰略經營模式正在推動該市場的產生收入。

目錄

第1章調查方法和範圍

第2章執行概述

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章誘導性多功能幹細胞生產市場：流程業務分析

  • 技術細分儀表板
  • 全球誘導性多功能幹細胞生產市場流程及波動分析
  • 2018-2030年全球誘導性多功能幹細胞生產市場規模及趨勢分析（依製程）
  • 手動 iPSC 生產流程
  • 自動化 iPSC 生產流程

第5章誘導性多功能幹細胞生產市場：工作流程業務分析

  • 工作流程細分儀表板
  • 全球誘導性多功能幹細胞生產市場的流程變化分析
  • 2018-2030年全球誘導性多功能幹細胞生產市場規模及趨勢分析（依工作流程）
  • 重新程式設計
  • 細胞培養
  • 細胞表徵/分析
  • 工程
  • 其他

第6章誘導性多功能幹細胞生產市場：產品業務分析

  • 產品細分儀表板
  • 全球誘導性多功能幹細胞生產市場產品波動分析
  • 2018-2030年全球誘導性多功能幹細胞生產市場規模及趨勢分析（分產品）
  • 設備/設備
  • 自動化平台
  • 耗材和套件
  • 服務

第7章誘導性多功能幹細胞生產市場：應用業務分析

  • 範例類型細分儀表板
  • 全球誘導性多功能幹細胞生產市場應用變化分析
  • 2018-2030年全球誘導性多功能幹細胞生產市場規模及趨勢分析（依應用）
  • 藥物開發和發現
  • 再生醫學
  • 毒理學研究
  • 其他

第8章誘導性多功能幹細胞生產市場：最終用途業務分析

  • 最終用途細分儀表板
  • 全球誘導性多功能幹細胞生產市場的最終用途變化分析
  • 2018-2030年全球誘導性多功能幹細胞生產市場規模與趨勢分析（依最終用途）
  • 研究/學術機構
  • 生物技術和製藥公司
  • 醫院/診所

第9章誘導性多功能幹細胞生產市場：按流程、工作流程、產品、應用和最終用途進行區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測與趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第10章競爭格局

  • 參與企業
  • 策略規劃
  • 2023 年企業市場分析
  • 參與企業概況
    • Lonza
    • Axol Bioscience Ltd.
    • Evotec
    • REPROCELL Inc.
    • STEMCELL Technologies
    • Merck KGaA
    • Fate Therapeutics
    • Thermo Fisher Scientific, Inc.
    • Catalent, Inc
    • Applied StemCells, Inc.

第11章分析師的觀點

Product Code: GVR-4-68039-549-7

Induced Pluripotent Stem Cells Production Market Growth & Trends:

The global induced pluripotent stem cells production market size is expected to reach USD 2.76 billion by 2030, registering a CAGR of 9.44% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increase in demand for induced pluripotent stem cells (iPSCs) in comparison to Embryonic Stem Cells (ESCs) has offered a significant drive to the market. Advantages such as no stem cell-related ethical issues, personalized treatment, and flexibility during cell-based research have created a favorable scenario for market growth. In addition, the prevalence of chronic disorders is also driving the growth of the induced pluripotent stem cells production market, as conditions like heart disease, stroke, diabetes, and many more can be treated by utilizing iPSCs-mediated therapy. For example, according to the International Diabetes Federation (IDF), 537 million people are already living with diabetes in 2021.

The rising research activities during COVID-19 pandemic have positively impacted the market. The pandemic fueled research in many fields as the SARS CoV-2 infection resulted in many diseases in the patients. For instance, in April 2021, researchers from USA stated that up to 25% of COVID-19 patients suffered cardiac dysfunction. Through their research article, they demonstrated the pathogenesis via exposure of iPSCs-derived cardiac cells to SARS CoV-2, and similar alterations were confirmed from human autopsy specimens of the patients. Such insights allow the use of induced pluripotent stem cells (iPSCs) as drug or therapy development platforms and their utilization in the management of the long-term effects of COVID-19.

Induced pluripotent stem cells are cells that are derived from adult somatic cells and then further reprogrammed to obtain the pluripotency as that of ESCs. These iPSCs are proving to be an ethically uncomplicated alternative for research that involves ESCs. The derivation of the ESCs is associated with the destruction of an embryo at the blastocyte stage, which has led to a maximum number of ethical debates. However, induced pluripotent stem cells have solved the ethical issue over the destruction of human embryos in research by involving only the genetic reprogramming of somatic cells. This has propelled the market growth and resulted in numerous applications including drug discovery, disease modeling, toxicology testing, and many others. For instance, in August 2021, Fate Therapeutics announced the treatment of the first patient with FT819 during clinical trials. FT819 is an engineered CAR-T cell therapy that is derived from iPSCs. Also, the rising focus of the research community on exploring applications of induced pluripotent stem cells in regenerative medicine due to their unique characteristics such as differential potential, self-renewable, immunomodulatory properties, and others; is set to drive the market expansion.

Induced Pluripotent Stem Cells Production Market Report Highlights:

  • By process, the manual iPSC production process segment dominated the market and accounted for the largest revenue share in 2023.
  • By workflow, the cell culture segment dominated the market with the largest revenue share of 37.34% in 2023. Cell culture workflow is inclusive of revenues generated from iPSC harvest products, expansion products, and differentiation products; thus contributing to the market relevance of this segment.
  • By product, the consumables and kits segment dominated the market and accounted for the largest revenue share of 40.32% in 2023. The never-ceasing research and development activities in the iPSCs space are driving the demand for various consumables & kits.
  • By application, drug development & discovery segment dominated the market with the largest revenue share of 43.33% in 2023.
  • By end-user, the biotechnology and pharmaceutical companies segment dominated the market with the largest revenue share of 59.35% in 2023. The availability and adoption of various kits, consumables, and instruments along with iPSCs products are driving the revenue generation in this segment.
  • North America dominated the market and accounted for the largest revenue share of 40.98% in 2023. The growing incidence of chronic diseases in this region, developed healthcare infrastructure, funds from private & government initiatives, and strategic business models are driving the revenue generation in the marketspace.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Process
    • 1.2.2. Workflow
    • 1.2.3. Product
    • 1.2.4. Application
    • 1.2.5. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing applications of regenerative medicine
      • 3.2.1.2. Technological advancements in ipsc production
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent process control and regulatory challenges
      • 3.2.2.2. High cost of production
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Induced Pluripotent Stem Cells Production Market: Process Business Analysis

  • 4.1. Technology Segment Dashboard
  • 4.2. Global Induced Pluripotent Stem Cells Production Market Process, Movement Analysis
  • 4.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Process, 2018 to 2030 (USD Million)
  • 4.4. Manual iPSC Production Process
    • 4.4.1. Global Manual iPSC Production Process Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Automated iPSC Production Process
    • 4.5.1. Global Automated iPSC Production Process Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Induced Pluripotent Stem Cells Production Market: Workflow Business Analysis

  • 5.1. Workflow Segment Dashboard
  • 5.2. Global Induced Pluripotent Stem Cells Production Market Workflow Movement Analysis
  • 5.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 5.4. Reprogramming
    • 5.4.1. Global Reprogramming Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cell Culture
    • 5.5.1. Global Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Cell Characterization/Analysis
    • 5.6.1. Global Cell Characterization/Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Engineering
    • 5.7.1. Global EngineeringMarket Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Induced Pluripotent Stem Cells Production Market: Product Business Analysis

  • 6.1. Product Segment Dashboard
  • 6.2. Global Induced Pluripotent Stem Cells Production Market Product Movement Analysis
  • 6.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 6.4. Instrument/Devices
    • 6.4.1. Global Instrument/Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Automated Platforms
    • 6.5.1. Global Automated Platforms Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Consumables & Kits
    • 6.6.1. Global Consumables & Kits Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Media
      • 6.6.2.1. Global Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Kits
      • 6.6.3.1. Global Kits Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. Others
      • 6.6.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Services
    • 6.7.1. Global Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Induced Pluripotent Stem Cells Production Market: Application Business Analysis

  • 7.1. Sample Type Segment Dashboard
  • 7.2. Global Induced Pluripotent Stem Cells Production Market Application Movement Analysis
  • 7.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Drug Development and Discovery
    • 7.4.1. Global Drug Development and Discovery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Regenerative Medicine
    • 7.5.1. Global Regenerative Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Toxicology Studies
    • 7.6.1. Global Toxicology Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Induced Pluripotent Stem Cells Production Market: End Use Business Analysis

  • 8.1. End Use Segment Dashboard
  • 8.2. Global Induced Pluripotent Stem Cells Production Market End Use Movement Analysis
  • 8.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Research & Academic Institutes
    • 8.4.1. Global Research & Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Biotechnology & Pharmaceutical Companies
    • 8.5.1. Global Biotechnology & Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Hospitals & Clinics
    • 8.6.1. Global Hospitals & Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Induced Pluripotent Stem Cells Production Market: Regional Estimates & Trend Analysis by Process, Workflow, Product, Application, & End Use

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 9.3. North America
    • 9.3.1. North America Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Mexico Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. UK Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Germany Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. Australia Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. Thailand Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. South Korea Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Argentina Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Saudi Arabia Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. UAE Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2023
  • 10.4. Participant's Overview
    • 10.4.1. Lonza
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Axol Bioscience Ltd.
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Evotec
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. REPROCELL Inc.
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. STEMCELL Technologies
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Merck KGaA
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Fate Therapeutics
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. Thermo Fisher Scientific, Inc.
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Catalent, Inc
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Applied StemCells, Inc.
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

Chapter 11. Analyst View

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 5 Global induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 Global induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 8 Global induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 11 North America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 12 North America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 13 North America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 14 North America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 15 U.S. induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 16 U.S. induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 17 U.S. induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 U.S. induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 19 U.S. induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Canada induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 21 Canada induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 22 Canada induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 23 Canada induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 24 Canada induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Mexico induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 26 Mexico induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 27 Mexico induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 28 Mexico induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 29 Mexico induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Europe induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
  • Table 31 Europe induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 32 Europe induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 33 Europe induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 34 Europe induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 35 Europe induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 36 UK induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 37 UK induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 38 UK induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 UK induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 40 UK induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Germany induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 42 Germany induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 43 Germany induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 44 Germany induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 45 Germany induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 46 France induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 47 France induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 48 France induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 49 France induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 50 France induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Italy induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 52 Italy induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 53 Italy induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 54 Italy induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 55 Italy induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Spain induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 57 Spain induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 58 Spain induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 59 Spain induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 60 Spain induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Denmark induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 62 Denmark induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 63 Denmark induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 64 Denmark induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 65 Denmark induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Sweden induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 67 Sweden induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 68 Sweden induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 69 Sweden induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 70 Sweden induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Norway induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 72 Norway induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 73 Norway induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 74 Norway induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 75 Norway induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Japan induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 83 Japan induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 84 Japan induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 85 Japan induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 86 Japan induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 87 China induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 88 China induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 89 China induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 90 China induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 91 China induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 92 India induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 93 India induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 94 India induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 95 India induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 96 India induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 97 Australia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 98 Australia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 99 Australia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 100 Australia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 101 Australia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 102 Thailand induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 103 Thailand induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 104 Thailand induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 105 Thailand induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 106 Thailand induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 107 South Korea induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 108 South Korea induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 109 South Korea induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 110 South Korea induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Korea induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Latin America induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
  • Table 113 Latin America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 114 Latin America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 115 Latin America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 116 Latin America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 117 Latin America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 118 Brazil induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 119 Brazil induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 120 Brazil induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 121 Brazil induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 122 Brazil induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 123 Argentina induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 124 Argentina induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 125 Argentina induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 126 Argentina induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 127 Argentina induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 134 South Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 135 South Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 136 South Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 137 South Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 138 South Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 144 UAE induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 145 UAE induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 146 UAE induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 147 UAE induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 148 UAE induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 150 Kuwait induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 151 Kuwait induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 152 Kuwait induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 153 Kuwait induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 154 Participant's overview
  • Table 155 Financial performance
  • Table 156 Key companies undergoing expansions
  • Table 157 Key companies undergoing acquisitions
  • Table 158 Key companies undergoing collaborations
  • Table 159 Key companies launching new products
  • Table 160 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Induced pluripotent stem cells production market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Induced pluripotent stem cells production market driver analysis
  • Fig. 12 Induced pluripotent stem cells production market restraint analysis
  • Fig. 13 Induced pluripotent stem cells production market: Porter's analysis
  • Fig. 14 Induced pluripotent stem cells production market: PESTEL analysis
  • Fig. 15 Induced pluripotent stem cells production market: Product outlook and key takeaways
  • Fig. 16 Induced pluripotent stem cells production market: Product market share analysis, 2023 - 2030
  • Fig. 17 Global induced pluripotent stem cells production by instruments/devices market, 2018 - 2030 (USD Million)
  • Fig. 18 Global induced pluripotent stem cells production by automated platforms market, 2018 - 2030 (USD Million)
  • Fig. 19 Global induced pluripotent stem cells production by consumables & kits market, 2018 - 2030 (USD Million)
  • Fig. 20 Global induced pluripotent stem cells production by kits market, 2018 - 2030 (USD Million)
  • Fig. 21 Global induced pluripotent stem cells production by media market, 2018 - 2030 (USD Million)
  • Fig. 22 Global induced pluripotent stem cells production by others market, 2018 - 2030 (USD Million)
  • Fig. 23 Global induced pluripotent stem cells production by services market, 2018 - 2030 (USD Million)
  • Fig. 24 Induced pluripotent stem cells production market: Process outlook and key takeaways
  • Fig. 25 Induced pluripotent stem cells production market: Process market share analysis, 2023 - 2030
  • Fig. 26 Global induced pluripotent stem cells production by manual iPSC production process market, 2018 - 2030 (USD Million)
  • Fig. 27 Global induced pluripotent stem cells production by automated iPSC production process market, 2018 - 2030 (USD Million)
  • Fig. 28 Induced pluripotent stem cells production market: Workflow outlook and key takeaways
  • Fig. 29 Induced pluripotent stem cells production market: Workflow market share analysis, 2023 - 2030
  • Fig. 30 Global induced pluripotent stem cells production by reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 31 Global induced pluripotent stem cells production by cell culture market, 2018 - 2030 (USD Million)
  • Fig. 32 Global induced pluripotent stem cells production by cell characterization/analysis market, 2018 - 2030 (USD Million)
  • Fig. 33 Global induced pluripotent stem cells production by engineering market, 2018 - 2030 (USD Million)
  • Fig. 34 Global induced pluripotent stem cells production by others market, 2018 - 2030 (USD Million)
  • Fig. 35 Induced pluripotent stem cells production market: Application outlook and key takeaways
  • Fig. 36 Induced pluripotent stem cells production market: Application market share analysis, 2023 - 2030
  • Fig. 37 Global induced pluripotent stem cells production by drug development & discovery market, 2018 - 2030 (USD Million)
  • Fig. 38 Global induced pluripotent stem cells production by regenerative medicine market, 2018 - 2030 (USD Million)
  • Fig. 39 Global induced pluripotent stem cells production by toxicology studies market, 2018 - 2030 (USD Million)
  • Fig. 40 Global induced pluripotent stem cells production by others market, 2018 - 2030 (USD Million)
  • Fig. 41 Induced pluripotent stem cells production market: End use outlook and key takeaways
  • Fig. 42 Induced pluripotent stem cells production market: End use market share analysis, 2023 - 2030
  • Fig. 43 Global induced pluripotent stem cells production by research & academic institutes market, 2018 - 2030 (USD Million)
  • Fig. 44 Global induced pluripotent stem cells production by biotechnology & pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 45 Global induced pluripotent stem cells production by hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 North America induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Canada induced pluripotent stem cells production market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Europe induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 UK induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Germany induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 France induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Italy induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Spain induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Denmark induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Norway induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Asia-Pacific induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Japan induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 China induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 India induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Australia induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Thailand induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 South Korea induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 MEA induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Saudi Arabia induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 UAE induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Key company categorization
  • Fig. 76 Company market positioning
  • Fig. 77 Market participant categorization
  • Fig. 78 Strategy framework